Certified by Founder Lodge
Ambrosia Biosciences Inc.
United States - Boulder, CO
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 21 ,2024 | Series A | $16,000,000 | |
| December, 12 ,2024 | Series A | $25,000,000 |
Boulder Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
